Drynaria fortunei (D. fortunei), widely used in traditional Korean medicine, is reportedly effective in treating inflammation, hyperlipidemia, bone fractures, oxidative damage, arteriosclerosis, rheumatism, and gynecological diseases. The objective of this study was to evaluate the antibacterial effects of the chloroform fraction of D. fortunei (DFCF) and assess the synergistic effects of DFCF with antibiotics against bacterial pathogens. This was carried out by calculating the minimal inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) and performing checkerboard dilution test and time-kill assays. The MICs/MBCs for DFCF, ampicillin, and gentamicin against all oral strains were >39-2,500/5,000 μg/mL, 0.25-64/0.25-64 µg/mL, and 0.5-256/1-512 µg/mL, respectively. DFCF exhibited the highest activity against the periodontic pathogens Prevotella intermedia and Porphylomonas gingivalis. DFCF in combination with ampicillin showed a strong synergistic effect against oral bacteria (fractional inhibitory concentration (FIC) index ≤0.5), whereas on combining with gentamicin, it reduced the on half-eighth times than used alone (FICI ≤ 0.5). DFCF combined with ampicillin or gentamicin killed 100% of most tested bacteria within 3-4 h. The results of this study demonstrate the antimicrobial and synergistic activity of DFCF and antibiotics against oral pathogens.
Introduction
The human oral microbiome contains approximately 700 predominant bacterial species that protect the oral cavity (1, 2) . However, the oral microbiota are often involved in the pathogenesis of a variety of systemic diseases including respiratory infections, cancer, diabetes mellitus, rheumatoid arthritis, cardiovascular diseases, brain abscess, and premature birth (3) (4) (5) . Dental caries and periodontal diseases are the most common oral and dental diseases (6, 7) . The bacteria living in the oral cavity occur in the form of biofilms and bacterial plaque accumulated on solid surfaces, such as the tooth enamel, fillings, restorations, and orthodontic appliances, and play a role in the etiology and pathogenesis of periodontal disease and dental caries, often resulting in teeth loss if left untreated (4, 8) . The accumulation of plaque around the gingival and subgingival regions may lead to a change in the microbial composition from predominantly Mutans streptococci to a larger number of Actinomyces spp., and capnophilic and obligatory anaerobic bacteria such as Porphyromonas gingivalis (P. gingivalis) (9) (10) (11) . Several antiseptic agents including chlorhexidine, cetylpyridinium chloride, fluorides, phenol derivatives, ampicillin, erythromycin, penicillin, tetracycline, and vancomycin have been used widely in dentistry to reduce bacterial growth (12) (13) (14) . However, these chemicals may disturb the oral and intestinal flora, and may cause side effects such as microbe susceptibility, vomiting, diarrhea, and tooth staining (15) (16) (17) . In order to address these issues, natural antimicrobial agents with fewer side effects and specificity for oral pathogens should be studied further. Plants have a large number of biologically active compounds, many of which have been reported to have antimicrobial properties (18) (19) (20) .
Drynaria fortunei (D. fortunei; Gol-Se-Bo in Korean and Gu-Sui-Bu in Chinese), a traditional Korean medicine, has been known to be effective in treating inflammation, hyperlipidemia, arteriosclerosis, rheumatism, gynecological diseases, osteoporosis, and bone resorption (21) (22) (23) (24) (25) . It is also used for treatment and prevention of orthopedic diseases, and is known to promote bone healing (22, 26) . Previous studies have reported that it exhibited antioxidant effects on rat osteoblasts undergoing hydrogen peroxide-induced death, and promoted the restoration of bone under similar pathologic conditions (27) . The water extract of D. fortunei has been exhibited to have a significant protective effect against ototoxicity caused by treptomycin, streptomycin, and kanamycin in humans, and also inhibit the progression of bone loss induced by ovariectomy in rats (28, 29) .
This study aimed to determine the antimicrobial effects of the chloroform fraction of D. fortunei (DFCF) on the growth of cariogenic and periodontic pathogens. Additionally, a combination of DFCF with currently used antibiotics was also investigated. were identified using the broth dilution method. Facultative anaerobic bacteria were incubated with Brain-Heart Infusion broth (BHI; Difco Laboratories, Detroit, MI, USA) for 18 h at 37°C. BHI supplemented with 1% yeast extract (Difco) was used to incubate A. actinomycetemcomitans, F. nucleatum, and P. intermedia for 24 h at 37°C, and BHI containing hemin (Sigma Aldrich, St Louis, MO, USA) and menadione (Sigma Aldrich) was used for incubating the obligate anaerobic bacteria, P. gingivalis, for 48 h at 37°C.
Materials and Methods

Plant material and preparation of crude
Minimum inhibitory concentrations/minimum bactericidal concentrations assay
The minimum inhibitory concentration (MIC) of the CHCl 3 DFCF was determined using the broth dilution method, and this was repeated three times. The antibacterial activities were recorded after incubation at 37°C for 18-48 h under anaerobic conditions. MIC was defined as the lowest concentration of tested DFCF that completely inhibited visible growth in the broth. To measure the minimum bactericidal concentration (MBC), the lowest concentration of tested DFCF was subcultured on appropriate agar plates. The number of colonies were counted and compared with the number of CFU/mL in the original inoculum after 24-48 h. The lowest concentration of DFCF that could kill 99.9% of bacteria was defined as the MBC.
Checker board dilution test
The combination of DFCF and antibiotics (ampicillin and gentamicin, Sigma) was determined using a checkerboard test against oral pathogens, as previously described (30, 31) . Combination assays were examined in 24-well plates, where the first agent was diluted twofold, followed by addition of the second agent at various concentrations. Thereafter, the bacteria were added to each well and incubated at 37°C for 24-48 h. The interaction was identified as being synergistic if the fraction inhibitory concentration (FIC)/fraction bactericidal concentration (FBC) index was less than or equal to 0.5, additive if the FIC/FBC index was greater than 0.5 and less than or equal to 1.0, indifferent if the FIC/FBC index was greater than 1.0 and less than or equal to 2.0, and antagonistic if the FIC/FBC index was greater than 2.0 (31).
Time-kill curves
The bactericidal activities of the DFCF were also estimated using time-kill curves on oral pathogens. Tubes containing 1/2 MIC of DFCF with antibiotics individually or in combination were inoculated with a suspension having a final bacterial count of approximately 1×10 6 -5×10 6 CFU/mL. After incubation, 100 µL of bacterial aliquots were spread onto BHI agar to allow counting of the colony-forming units (CFU).
Statistical analysis
The data have been presented as mean and S.E. for each individual experiment. One-way analysis of variance (ANOVA) was used to analyze the data, and P values less than 0.05 were considered statistically significant.
Results
Antibacterial activity: MICs/MBCs
DFCF exhibited antibacterial effects against all tested oral bacteria in a dose-dependent manner (Fig. 1 Fig. 1 ). The MICs were either 0.25/0.25 or 64/64 μg/ mL for ampicillin, and 0.5/1 or 256/512 μg/mL (Table  1) for gentamicin. The range of MIC 50 and MIC 90 was 9-313 µg/mL and 39-2,500 µg/mL, respectively. The DFCF showed stronger antimicrobial activity against S. gordonii, P. intermedia, and P. gingivalis compared to other bacteria (MIC/MBC, 39-78/39-156 µg/mL), and the range of MIC 50 and MIC 90 was 9 µg/mL and 39-78 µg/mL, respectively.
Combined effects: bacteriostatic synergism
The FIC and FBC indices for DFCF combined with ampicillin or gentamicin against oral bacteria have been presented in Tables 2 and 3 , respectively. The combination of DFCF with ampicillin exhibited ≥4-8-fold reduction of the MICs for all tested bacteria except S. criceti, indicating a synergistic effect (FICI values of ≤0.25-0.5), and MBCs were shown as synergistic effect by FBCI values of ≤0.5, except S. mutans and S. creceti (FBCI values of ≥0.5) ( Table 2 ). The combination of DFCF and gentamicin resulted in a ≥4-8-fold reduction of MIC/MBCs for all tested bacteria, with the ranges of 9-313/9-1250 μg/mL for gentamicin becoming 0.125-32/0.25-64 μg/ mL. The FICI/FBCI indicated synergistic interactions for the combination of DFCF and gentamicin (FICI/FBCI values ≤0.125-0.5/0.5) for S. sanguinis, S. sobrinus, S. gordonii, A. actinomycetemcomitans, F. nucleatum, P. intermedia, and P. gingivalis, except S. mutans, S. ratti, S. criceti, and S. anginosus with additive (FICI/FBCI values of ≥0.75/≥0.75-1.0) ( Table 3) .
Combined effects: time-kill curve
The time-kill curve assay was used to examine the synergistic effect of DFCF with ampicillin or/and gentamicin against oral bacteria. Bacteria cultured at a cell density of 10 6 CFU/mL were exposed to MICs of the DFCF alone or in combination with ampicillin or/and gentamicin. The combination with antibiotics exhibited a time-dependent increase in rate of killing, measured in CFU/mL than DFCF alone. The combination of 1/2 MIC DFCF with 1/2 MIC ampicillin or 1/2 gentamicin killed 100% of the bacteria within 3 and 4 h (Fig. 2) . The results confirmed the synergistic effect of DFCF with antibiotics against oral bacteria. 
Discussion
The use of medicinal plants may be considered a suitable alternative for the treatment of different pathological diseases. A large range of plant extracts have been shown to have antimicrobial effects and this can contribute to the development of new drugs, thus generating a significant improvement in management of various health disorders (20, 32, 33) .
In the present study, DFCF exhibited strong antibac- terial activity against oral bacteria in a dose and time dependent manner. The MIC and MBC values of DFCF were shown on 39-313 µg/mL and 39-625 mg/mL in tested bacteria, respectively, except for A. actinomy-cetemcomitans and F. nucleatum where the MICs/MBCs values were shown on 1,250-2,500/1,250-5,000 µg/mL. The most sensitive bacterial strains were the periodontal pathogens such as P. intermedia and P. gingivalis (MIC/ MBCs ranging from 39/39-78 µg/mL) and the cariogenic species including S. sobrinus and S. gordonii (MIC/MBC = 78/156 µg/mL). Antibacterial agents such as chlorhexidine, ampicillin, erythromycin, penicillin, tetracycline, vancomycin, cetylpyridinium chloride, triclosan, and chlorine dioxide have been shown to have side effects when tested alone or in combination (34) (35) (36) (37) (38) . In recent years, several studies have reported that various plant extracts or their derivatives can reduce these side effects (39, 40) , although some combinations of natural materials and antibiotics may affect the inhibitory effect of these antibiotics (41, 42) .
The n-BuOH, MeOH, and H 2 O extracts of D. fortunei contain alkaloids, phenolics, glycosides, proteins, and flavonoids. The CHCl 3 extract contains naringin, hesperidin, caffeic acid, and procyanidin, but flavonoids was detected only in the n-BuOH extract for presence of organic acid (21, 22, 25, 28, 43) . Some of the polyphenols isolated from plants exhibit anti-carious effects such as growth inhibition and inhibition of glucosyltransferases against mutans streptococci (44) (45) (46) . Flavonoid complexes attach with extracellular soluble proteins and the bacterial cell wall, and exhibit antibacterial activity (47, 48) . As DFCF is composed of many flavonoids, it may exhibit strong antibacterial activity against oral bacteria.
The combination of DFCF with ampicillin or gentamicin showed a rapid killing rate for all tested bacteria, eradicating almost 100% of the bacteria within 3-4 h. Moreover, this differential effect of D. fortunei extract and fractions on bacteria associated with caries and oral periodontal pathogens was also reflected in the time-kill curves performed for S. mutans and P. gingivalis, where Streptococcus was killed much slower than Porphyromonas. As D. fortunei is composed of many flavonoids, it may exhibit strong antibacterial activity against oral bacteria.
In conclusion, this study presents preliminary evidence of the antimicrobial activity of DFCF against oral bacterial species. It seems likely been the development of a new oral therapies.
